FDA Approval Of InPen

On June 18, 2020, the U.S. Food and Drug Administration (FDA) published this approval of the InPen medical device as for diabetes management. The InPen is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin . . .